The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice

PURPOSE: Malignant pleural mesothelioma (MPM) is a highly lethal neoplasm. S-1 has been developed as a novel oral antineoplastic agent based on the modulation of 5-fluorouracil (5-FU) bioactivity. This study was conducted to investigate the preclinical therapeutic effect of S-1 on MPM. METHODS: We u...

Descripción completa

Detalles Bibliográficos
Autores principales: Van, Trung The, Hanibuchi, Masaki, Kakiuchi, Soji, Sato, Seidai, Kuramoto, Takuya, Goto, Hisatsugu, Mitsuhashi, Atsushi, Nishioka, Yasuhiko, Akiyama, Shin-ichi, Sone, Saburo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143341/
https://www.ncbi.nlm.nih.gov/pubmed/21079960
http://dx.doi.org/10.1007/s00280-010-1503-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143341/
https://www.ncbi.nlm.nih.gov/pubmed/21079960
http://dx.doi.org/10.1007/s00280-010-1503-x

Ejemplares similares